Login to Pancreatic Cancer UK

news hero image

APPG on Pancreatic Cancer launches Research Report

Posted by: Policy and campaigning 29 October 2014

 Today the All Party Parliamentary Group on Pancreatic Cancer launched their report setting out what needs to be done to increase the amount of research into pancreatic cancer.

Jeremy Hunt , Jane Ellison , Eric Ollerenshaw , Alex Ford And SuggsL-R: Suggs, Secretary of State for Health Jeremy Hunt MP, Chair of the APPG on pancreatic cancer Eric Ollerenshaw MP, CEO of Pancreatic Cancer UK Alex Ford, Minister for Public Health Jane Ellison MP

The report follows a six month Inquiry which took written and oral evidence from a range of experts and stakeholders.

In addition to acting as the Secretariat for the APPG, Pancreatic Cancer UK provided its own evidence, pressing for changes to ensure an increase in funding and a larger number of researchers working on pancreatic cancer. We were also proud to sponsor the report launch event.

Pancreatic Cancer Researchers And Clinicians , Eric Ollerenshaw And SuggsResearchers who gave evidence during the enquiry with Eric Ollerenshaw MP (Chair of the APPG on pancreatic cancer) and Suggs

You can read the full report here but the key recommendations include:

  • There needs to be more money spent on pancreatic cancer research, with up to £25 million being spent by 2025 and funders should ring-fence money for pancreatic cancer research, at least in the short term, to allow the necessary increase to happen.
  • A key area of focus for research should be in early diagnosis, including efforts to develop a screening test for pancreatic cancer.
  • New initiatives and evaluation schemes should prioritise cancers of unmet need, including pancreatic cancer. This would mean including pancreatic cancer in the Human Genome project and including technologies like Nanoknife on the NHS England Commissioning through Evaluation scheme.
  • Bureaucracy needs to be reduced so that clinical trials can be set up more quickly. There also needs to be a culture of research embedded across the whole of the NHS.
  • The National Institute for Health and Care Excellence needs to amend its drug appraisal process so that more drugs for cancers of unmet need, including pancreatic cancer, are approved for routine use. This will help allow more trials of new drug combinations to take place.
  • More scholarships, fellowships and other programmes should be created to encourage more promising young scientists into the pancreatic cancer research field.
  • A country-wide research strategy for cancers of unmet need – including pancreatic cancer – should be drawn up. This would be the UK’s own version of the USA’s Recalcitrant Cancer Research Act 2012.

We are delighted that the report has produced some robust recommendations that we believe will have a real positive impact on pancreatic cancer if implemented.

More photos of the event can be found on Facebook!